|
1
|
Grasser KD, Wurz A and Feix G: Isolation
and characterization of high-mobility-group proteins from maize.
Planta. 185:350–355. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bianchi ME and Agresti A: HMG proteins:
Dynamic players in gene regulation and differentiation. Curr Opin
Genet Dev. 15:496–506. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gerlitz G: HMGNs, DNA repair and cancer.
Biochim Biophys Acta. 1799:80–85. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rochman M, Taher L, Kurahashi T, Cherukuri
S, Uversky VN, Landsman D, Ovcharenko I and Bustin M: Effects of
HMGN variants on the cellular transcription profile. Nucleic Acids
Res. 39:4076–4087. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shimahara H, Hirano T, Ohya K, Matsuta S,
Seeram SS and Tate S: Nucleosome structural changes induced by
binding of non-histone chromosomal proteins HMGN1 and HMGN2. FEBS
Open Bio. 3:184–119, 12013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Subramanian M, Gonzalez RW, Patil H, Ueda
T, Lim JH, Kraemer KH, Bustin M and Bergel M: The
nucleosome-binding protein HMGN2 modulates global genome repair.
FEBS J. 276:6646–6657. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vestner B, Bustin M and Gruss C:
Stimulation of replication efficiency of a chromatin template by
chromosomal protein HMG-17. J Biol Chem. 273:9409–9414. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fiorillo AA, Medler TR, Feeney YB, Liu Y,
Tommerdahl KL and Clevenger CV: HMGN2 inducibly binds a novel
transactivation domain in nuclear PRLr to coordinate
Stat5a-mediated transcription. Mol Endocrinol. 25:1550–1564. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Arnold LF and Baram P: In vitro culture of
periodontal ligament cells. J Dent Res. 51:953–959. 1972.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hock R, Furusawa T, Ueda T and Bustin M:
HMG chromosomal proteins in development and disease. Trends Cell
Biol. 17:72–79. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bustin M: Revised nomenclature for high
mobility group (HMG) chromosomal proteins. Trends Biochem Sci.
26:152–153. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Reeves R: Nuclear functions of the HMG
proteins. Biochim Biophys Acta. 1799:3–14. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gonzálezromero R, Eirínlópez JM and Ausió
J: Evolution of high mobility group nucleosome-binding proteins and
its implications for vertebrate chromatin specialization. Mol Biol
Evol. 32:121–131. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang Q and Wang Y: HMG modifications and
nuclear function. Biochim Biophys Acta. 28:1799: 28–36. 2010.
|
|
15
|
Kugler JE, Deng T and Bustin M: The HMGN
family of chromatin-binding proteins: Dynamic modulators of
epigenetic processes. Biochim Biophys Acta. 1819:652–656. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Furusawa T and Cherukuri S: Developmental
function of HMGN proteins. Biochim Biophys Acta. 1799:692010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Raymond R: High mobility group (HMG)
proteins: Modulators of chromatin structure and DNA repair in
mammalian cells. DNA Repair (Amst). 36:122–136. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu BL and Wan Y: Research progression
about the HMGN protein in tumor. J Int Oncol. 1–281. 2016.
|
|
19
|
Wei F, Yang F, Jiang X, Yu W and Ren X:
High-mobility group nucleosome-binding protein 1 is a novel
clinical biomarker in non-small cell lung cancer. Tumor Biol.
36:9405–9410. 2015. View Article : Google Scholar
|
|
20
|
Nie Y, Yang D and Oppenheim JJ: Alarmins
and antitumor immunity. Clin Ther. 38:1042–1053. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li DQ, Hou YF, Wu J, Chen Y, Lu JS, Di GH,
Ou ZL, Shen ZZ, Ding J and Shao ZM: Gene expression profile
analysis of an isogenic tumour metastasis model reveals a
functional role for oncogene AF1Q in breast cancer metastasis. Eur
J Cancer. 42:3274–3286. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gan Y, Tan J, Yang J, Zhou Y, Dai Y, He L,
Yao K and Tang Y: Erratum to: Knockdown of HMGN5 suppresses the
viability and invasion of human urothelial bladder cancer 5,637
cells in vitro and in vivo. Med Oncol. 32:1612015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mohan G: Chromatin-binding HMGN proteins
and the neuronal differentiation of enbryonal carcinoma cells in
vitro. University of Glasgow. 2012.
|
|
24
|
Popescu N, Landsman D and Bustin M:
Mapping the human gene coding for chromosomal protein HMG-17. Human
Genet. 85:376–378. 1990. View Article : Google Scholar
|
|
25
|
Xie P, Deng LX, Gong P, Ding Y and Tang
XH: Expression of HMGB1 and HMGN2 in gingival tissues, GCF and PICF
of periodontitis patients and peri-implantitis. Braz J Microbiol.
42:1213–1219. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Deng LX, Wu GX, Cao Y, Fan B, Gao X, Tang
XH and Huang N: The chromosomal protein HMGN2 mediates the
LPS-induced expression of β-defensins in mice. Inflammation.
35:456–473. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Porkka K, Laakkonen P, Hoffman JA,
Bernasconi M and Ruoslahti E: A Fragment of the HMGN2 protein homes
to the nuclei of tumor cells and tumor endothelial cells in vivo.
Proc Natl Acad Sci USA. 99:pp. 7444–7449. 2002; View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chengqian Y, Shuai S, Xue W, Yuting Z and
Jianfa Y: Pathology Do: Research progress of high mobility group N2
in tumor. J Modern Oncol. 2016.
|
|
29
|
Porkka K, Laakkonen P, Hoffman JA,
Bernasconi M and Ruoslahti E: A fragment of the HMGN2 protein homes
to the nuclei of tumor cells and tumor endothelial cells in vivo.
Proc Natl Acad Sci USA. 99:pp. 7444–7449. 2002; View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Neville BW and Day TA: Oral cancer and
precancerous lesions. CA Cancer J Clin. 52:195–215. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Choi S and Myers JN: Molecular
pathogenesis of oral squamous cell carcinoma: Implications for
therapy. J Dent Res. 87:14–32. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Andishehtadbir A, Najvani AD, Pardis S,
Ashkavandi ZJ, Ashraf MJ, Khademi B and Kamali F:
Metastasis-associated protein 1 expression in oral squamous cell
carcinomas: Correlation with metastasis and Angiogenesis/Metastaz
İlişkili protein 1 ekspresyonunun oral Skuamöz Hücreli
karsinomlarda metastaz ve anjiyogenez ile İlişkisi. Turkish J
Pathol. 31:9–15. 2015.
|
|
33
|
Li SH, Tian H, Yue WM, Li L, Li WJ, Chen
ZT, Hu WS, Zhu YC and Qi L: Overexpression of metastasis-associated
protein 1 is significantly correlated with tumor angiogenesis and
poor survival in patients with early-stage non-small cell lung
cancer. Ann Surg Oncol. 18:2048–2056. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wu CC, Huang YS, Lee LY, Liang Y, Tang RP,
Chang YS, Hsieh LL and Yu JS: Overexpression and elevated plasma
level of tumor-associated antigen 90K/Mac-2 binding protein in
colorectal carcinoma. Proteomics Clin Appl. 2:1586–1595. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hu A, Dong X, Liu X, Zhang P, Zhang Y, Su
N, Chen Q and Feng Y: Nucleosome-binding protein HMGN2 exhibits
antitumor activity in oral squamous cell carcinoma. Oncol Lett.
7:115–120. 2014. View Article : Google Scholar : PubMed/NCBI
|
